GRITSTONE BIO, INC.

(GRTS)
  Report
Real-time Estimate Cboe BZX  -  03:31 2022-08-17 pm EDT
4.455 USD   -6.21%
07:01aGritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/15Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors
AQ
08/15Gritstone bio, Inc. Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart GRITSTONE BIO, INC.
Upcoming events on GRITSTONE BIO, INC.
11/15/22 Q3 2022 Earnings Release (Projected)
03/09/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
Past events on GRITSTONE BIO, INC.
08/04/22 | 04:30pm Interim 2022 Earnings Call
08/04/22 Interim 2022 Earnings Release
06/17/22 | 12:00pm Annual General Meeting
06/04/22 | 09:00am American Society of Clinical Oncology Meeting - Abstract Number TPS3635
05/24/22 | 07:00am H.C. Wainwright Global Life Sciences Investment Conference
05/12/22 | 04:00pm Q1 2022 Earnings Call
05/05/22 | 04:05pm Q1 2022 Earnings Release
05/03/22 Shareholders Meeting - Q&A
04/13/22 | 09:00am American Association of Cancer Research Meeting - Abstract Number 4149
04/12/22 | 02:30pm American Association of Cancer Research Meeting - Abstract Number 3578
Past dividends on GRITSTONE BIO, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread


 
1,19
2,00
-41%
4,37
4,56
-4,3%
4,04
3,89
3,7%
48,2
48,0
0,39%
 
19,2
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-39,8

 
-61,6
-53,2
-16%
-93,2
-93,5
0,33%
-99,4
-103
3,1%
-68,9
-65,8
-4,7%
 
-120
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-65,6
-58,1
-13%
-97,9
-95,4
-2,6%
-106
-107
0,58%
-75,2
-73,7
-2,1%
 
-124
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-64,8
-64,9
0,19%
-94,4
-93,0
-1,5%
-105
-105
-0,25%
-75,1
-73,9
-1,6%
 
-123
 
Net income
M $
Released
Forecast
Spread
-41,4

 
-64,8
-64,9
0,19%
-94,4
-93,0
-1,5%
-105
-105
-0,25%
-75,1
-73,9
-1,6%
 
-123
 
EPS
$
Released
Forecast
Spread
-20,7

 
-7,26
-1,90
-283%
-2,81
-2,63
-6,7%
-2,79
-2,71
-2,8%
-0,95
-1,08
12%
 
-1,55
 
Announcement Date05/04/201803/28/201903/11/202003/11/202103/10/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
2,84
2,24
27%
2,61
2,24
17%
3,06
2,86
7,0%
7,19
4,21
71%
5,47
3,19
71%
 
3,26
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-25,2
-32,5
23%
-28,2
-28,8
2,4%
-29,8
-28,3
-5,4%
-29,0
-30,5
5,2%
-29,7
-31,3
5,2%
 
-32,7
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-25,1
-32,9
24%
-28,1
-28,8
2,4%
-29,8
-28,6
-4,0%
-28,9
-30,5
5,2%
-29,5
-31,6
6,6%
 
-32,2
 
Net income
M $
Released
Forecast
Spread
-25,1
-31,6
20%
-28,1
-27,5
-2,3%
-29,8
-28,6
-4,0%
-28,9
-30,5
5,2%
-29,5
-31,6
6,6%
 
-32,2
 
EPS
$
Released
Forecast
Spread
-0,33
-0,56
41%
-0,36
-0,47
24%
-0,36
-0,40
9,2%
-0,34
-0,36
5,6%
-0,34
-0,41
17%
 
-0,42
 
Announcement Date08/05/202111/03/202103/10/202205/05/202208/04/2022-
Previous year Next Year
Upcoming sector events for GRITSTONE BIO, INC.
More events
Past sector events for GRITSTONE BIO, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise